L.B. Bohle will be showcasing three examples of its pharmaceutical processing technology for the manufacture of oral solid doses at Interphex 2026 in New York City: the QbCon 1 continuous granulation ...
The "Oral Solid Dosage Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Finished Dosage Form, Type of Packaging, Scale of Operation, Company Size, Therapeutic Area, and ...
Forma Life Sciences, which inherited BioDuro’s California production operations earlier this year, has officially launched as a CDMO with a focus on oral solid-dosage drugs. The new contract ...
The high-potent oral solid dosage (HP-OSD) contract manufacturing market is projected to grow from USD 6.59 billion in 2025 to USD 15.32 billion by 2035, reflecting a steady value-based CAGR of 8.8%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results